"Welcome, from all of the physicians and staff. Our group provides care for patients with endocrine conditions, including diabetes, thyroid disorders, and a broad spectrum of other hormonal disorders. Please explore our web site for detailed information about our practice."

During the past decade, Maryland Diabetes & Endocrine Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maryland Diabetes & Endocrine Associates" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Maryland Diabetes & Endocrine Associates" are "Type 1 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Maryland Diabetes & Endocrine Associates" in a lesser frequency.

Most popular intervention types in "Maryland Diabetes & Endocrine Associates" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Teplizumab" (1 trials) and "Teplizumab (MGA031)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maryland Diabetes & Endocrine Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Maryland Diabetes & Endocrine Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Maryland Diabetes & Endocrine Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maryland Diabetes & Endocrine Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".